Hype and expectations in tissue engineering

Regenerative Medicine
Anke J M OerlemansWim Jm M Dekkers

Abstract

Scientific progress and the development of new technologies often incite enthusiasm, both in scientists and the public at large, and this is especially apparent in discussions of emerging medical technologies, such as tissue engineering (TE). Future-oriented narratives typically discuss potential applications with much hype and expectations. In this article, we analyze the discourse on TE, its history and the promises present in the discourse surrounding it. Subsequently, we regard discussions about implantable bioartificial kidneys, and consider the concepts of hype and expectations in TE in general. Finally, we discuss what ethically responsible choices should be made in discussing TE to adequately deal with the scientific reality and public expectations surrounding this technology.

References

May 14, 1993·Science·R Langer, J P Vacanti
Jul 7, 2005·Tissue Engineering·P D EdelmanJ G Matheny
Sep 6, 2005·Lancet·Judith HohlfeldLee Ann Applegate
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Linda G Griffith, Melody A Swartz
Apr 25, 2006·Lancet·Anthony AtalaAlan B Retik
Jun 15, 2006·Tissue Engineering·Charles A Vacanti
Jun 15, 2006·Tissue Engineering·Robert M Nerem
Jul 1, 2006·Science·Robert Nerem, Frank Yin
Oct 31, 2006·Archives of Dermatological Research·Yves Poumay, Alain Coquette
May 1, 2007·Regenerative Medicine·Chris Mason
Sep 1, 2007·Biomaterials·Charles James KirkpatrickRonald E Unger
Sep 21, 2007·Biosensors & Bioelectronics·Yo TanakaTakehiko Kitamori
Nov 13, 2007·Journal of Electrocardiology·Leslie Tung, Joshua Cysyk
Jan 12, 2008·Reproductive Sciences·Hibret A AdissuSophie A Lelièvre
Jan 11, 2008·Annals of the New York Academy of Sciences·Kathrin Gassei, Stefan Schlatt
May 6, 2008·Tissue Engineering. Part B, Reviews·Grace N Li, Diane Hoffman-Kim
May 6, 2008·Tissue Engineering. Part B, Reviews·Saejeong Kim, Horst von Recum
Sep 12, 2008·Journal of Dermatological Science·Jessica JeanRoxane Pouliot
May 15, 2009·Regenerative Medicine·Chris Mason, Elisa Manzotti
Sep 29, 2009·Early Human Development·Dame Julia M Polak
Apr 1, 1995·Tissue Engineering·R M Nerem, A Sambanis
Feb 19, 2010·Tissue Engineering. Part B, Reviews·Anke J M OerlemansWim J M Dekkers
Sep 17, 2010·Journal of the Royal Society, Interface·Robert M Nerem
Apr 2, 2011·Tissue Engineering. Part B, Reviews·Anke J M OerlemansWim J M Dekkers
Nov 3, 2011·Science and Engineering Ethics·Zubin Master, David B Resnik
Dec 6, 2011·Biotechnology Advances·Fa-Ming ChenSongtao Shi
Mar 23, 2012·Journal of Cellular and Molecular Medicine·Raymund E HorchAndreas Arkudas
Sep 7, 2012·Safety and Health at Work·Gert van der Laan
Dec 12, 2012·Science and Engineering Ethics·A J M OerlemansW J M Dekkers
Dec 21, 2012·Tissue Engineering. Part B, Reviews·Matthew B Fisher, Robert L Mauck
Mar 29, 2014·Journal of Tissue Engineering and Regenerative Medicine·A M LeferinkL Moroni

❮ Previous
Next ❯

Citations

Jul 16, 2015·Journal of Anatomy·Katja Schenke-Layland, Sara Y Brucker
May 3, 2016·Materials·Lauren EdgarGiuseppe Orlando
Apr 9, 2020·World Journal of Stem Cells·Matteo ScopettiVittorio Fineschi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Science and Engineering Ethics
Zubin Master, David B Resnik
Frontiers in Bioscience : a Journal and Virtual Library
Yiping GuRandall J Lee
Medical Group Management Journal
R Nelson
© 2021 Meta ULC. All rights reserved